Performance and toxicity of different absorption enhancers used in the preparation of Poloxamer thermosensitive in situ gels for ketamine nasal administration

References

• Nakajima S, Suzuki T, Watanabe K, et al. Accelerating response to antidepressant treatment in depression: a review and clinical suggestions. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(2):259–264. Mar 17
   PubMed Web of Science ®Google Scholar
• Rush AJ, Trivedi MH, Stewart JW, et al. Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. AJP. 2011;168(7):689–701.
   Web of Science ®Google Scholar
• Parise EM, Alcantara LF, Warren BL, et al. Repeated ketamine exposure induces an enduring resilient phenotype in adolescent and adult rats. Biol Psychiatry. 2013;74(10):750–759. Nov 15
   PubMed Web of Science ®Google Scholar
• Singh JB, Fedgchin M, Daly E, et al. Intravenous Esketamine in adult treatment-resistant depression: a double-blind, double-randomization, placebo-controlled Study. Biol Psychiatry. 2016;80(6):424–431.
   PubMed Web of Science ®Google Scholar
• Zarate CA, Jr., Brutsche NE, Ibrahim L, et al. Replication of ketamine’s antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry. 2012;71(11):939–946.
   PubMed Web of Science ®Google Scholar
• Murrough JW, Iosifescu DV, Chang LC, et al. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. AJP. 2013;170(10):1134–1142.
   Web of Science ®Google Scholar
• Ozsoy Y, Gungor S. Nasal route: an alternative approach for antiemetic drug delivery. Expert Opin Drug Deliv. 2011;8(11):1439–1453.
   PubMed Web of Science ®Google Scholar
• Illum L. Nasal drug delivery: new developments and strategies. Drug Discov Today. 2002;7(23):1184–1189.
   PubMed Web of Science ®Google Scholar
• Xie MH, Ge M, Peng JB, et al. In-vivo anti-tumor activity of a novel poloxamer-based thermosensitive in situ gel for sustained delivery of norcantharidin. Pharm Dev Technol. 2018;20:1–22.
   Google Scholar
• Hao J, Zhao J, Zhang S, et al. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery. Colloids Surf B Biointerfaces. 2016;147:376–386.
   PubMed Web of Science ®Google Scholar
• Karavasili C, Fatouros DG. Smart materials: in situ gel-forming systems for nasal delivery. Drug Discov Today. 2016;21(1):157–166.
   PubMed Web of Science ®Google Scholar
• De Souza Ferreira SB, Moco TD, Borghi-Pangoni FB, et al. Rheological, mucoadhesive and textural properties of thermoresponsive polymer blends for biomedical applications. J Mech Behav Biomed Mater. 2015;55:164–178.
   PubMed Web of Science ®Google Scholar
• Chonkar A, Nayak U, Udupa N. Smart polymers in nasal drug delivery. Indian J Pharm Sci. 2015;77(4):367–375.
   PubMed Web of Science ®Google Scholar
• Hugo A, Maria Helena A, Paulo L, et al. Pluronic® F-127 and Pluronic Lecithin Organogel (PLO): main features and their applications in topical and transdermal administration of drugs. J Pharmacy Pharmaceutical Sci. 2012;15(4):592–605.
   PubMed Web of Science ®Google Scholar
• Dragicevic N, Atkinson JP, Maibach HI. Chemical penetration enhancers: classification and mode of action. Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement. Springer Berlin Heidelberg, 2015;11–27.
   Google Scholar
• Wei L, Ji Y, Gong W, et al. Preparation, physical characterization and pharmacokinetic study of paclitaxel nanocrystals. Drug Dev Ind Pharm. 2014;41(8):1–10.
   Web of Science ®Google Scholar
• Gavini E, Rassu G, Ferraro L, et al. Influence of polymeric microcarriers on the in vivo intranasal uptake of an anti-migraine drug for brain targeting. Eur J Pharm Biopharm. 2013;83(2):174–183.
   PubMed Web of Science ®Google Scholar
• Gavini E, Rassu G, Haukvik T, et al. Mucoadhesive microspheres for nasal administration of cyclodextrins. J Drug Target. 2009;17(2):168–179.
   PubMed Web of Science ®Google Scholar
• Aungst BJ. Absorption enhancers: applications and advances. Aaps J. 2012;14(1):10–18.
   PubMed Web of Science ®Google Scholar
• Maggio ET. Intravail: highly effective intranasal delivery of peptide and protein drugs. Expert Opin Drug Deliv. 2006;3(4):529–539.
   PubMedGoogle Scholar
• Lewis AL, Jordan F, Illum L. CriticalSorb: enabling systemic delivery of macromolecules via the nasal route. Drug Deliv and Transl Res. 2013;3(1):26–32.
   PubMed Web of Science ®Google Scholar
• Hinchcliffe M, Jabbal-Gill I, Smith A. Effect of chitosan on the intranasal absorption of salmon calcitonin in sheep. J Pharm Pharmacol. 2005;57(6):681–687.
   PubMed Web of Science ®Google Scholar
• Kamei N, Nielsen EJ, Khafagy el S, et al. Noninvasive insulin delivery: the great potential of cell-penetrating peptides. Ther Deliv. 2013;4(3):315–326.
   PubMedGoogle Scholar
• Merkus FW, Verhoef JC, Marttin E, et al. Cyclodextrins in nasal drug delivery. Adv Drug Deliv Rev. 1999;36(1):41–57.
   PubMed Web of Science ®Google Scholar
• Parhizkar E, Emadi L, Alipour S. Development and evaluation of midazolam in situ nasal gel properties in presence of solubility enhancers at cilia-friendly pH. Macromol Res. 2017;25(3):255–261.
   Web of Science ®Google Scholar
• Esther DG, Basstanie JB, Roger CA. Embrechts Nico Rudolph Niemeijer, inventor; Janssen Pharmiaceutica nv, assignee. Pharmaceutical Comiposttion of S-Ketamiinne Hydrochiloride patent US20140275276A1. 2014.
   Google Scholar
• Sherif S, Bendas ER, Badawy S. The clinical efficacy of cosmeceutical application of liquid crystalline nanostructured dispersions of alpha lipoic acid as anti-wrinkle. Eur J Pharm Biopharm. 2014;86(2):251–259.
   PubMed Web of Science ®Google Scholar
• Cai X, Luan Y, Jiang Y, et al. Huperzine A-phospholipid complex-loaded biodegradable thermosensitive polymer gel for controlled drug release. Int J Pharm. 2012;433(1-2):102–111.
   PubMed Web of Science ®Google Scholar
• Na L, Mao S, Wang J, et al. Comparison of different absorption enhancers on the intranasal absorption of isosorbide dinitrate in rats. Int J Pharm. 2010;397(1-2):59–66.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Maitani Y, Ando T, et al. High absorbency and subchronic morphologic effects on the nasal epithelium of a nasal insulin powder dosage form with a soybean-derived sterylglucoside mixture in rabbits. Biol Pharm Bull. 1998;21(8):866–870.
   PubMed Web of Science ®Google Scholar
• Shelke S, Shahi S, Jalalpure S, et al. Poloxamer 407-based intranasal thermoreversible gel of zolmitriptan-loaded nanoethosomes: formulation, optimization, evaluation and permeation studies. J Liposome Res. 2016;26(4):313–323.
   PubMed Web of Science ®Google Scholar
• Cao SL, Zhang QZ, Jiang XG. Preparation of ion-activated in situ gel systems of scopolamine hydrobromide and evaluation of its antimotion sickness efficacy. Acta Pharmacol Sin. 2007;28(4):584–590.
   PubMed Web of Science ®Google Scholar
• Ko Ups DY, Yeoh B, Jeong B. Recent progress of in situ formed gels for biomedical applications. Progress Polymer Sci. 2012;38:672–701.
   Web of Science ®Google Scholar
• Lee WA, Narog BA, Patapoff TW, et al. Intranasal bioavailability of insulin powder formulations: effect of permeation enhancer-to-protein ratio. J Pharm Sci. 1991;80(8):725–729.
   PubMed Web of Science ®Google Scholar
• Nicolaas GM, Schipper SG, Romeijn JC, Verhoef,  et al. Nasal insulin delivery with dimethyl-beta-cyclodextrin as an absorption enhancer in rabbits: powder more effective than liquid formulations. Pharmaceutical Research. 1993;10(5):682–686.
   Google Scholar
• Galgatte UC, Kumbhar AB, Chaudhari PD. Development of in situ gel for nasal delivery: design, optimization, in vitro and in vivo evaluation. Drug Deliv. 2014;21(1):62–73.
   PubMed Web of Science ®Google Scholar